JOMOL E THOMAS

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Acute Care HOUSTON, TX NPI 1306371992

General Payments — all program years on this page

$1,436.59

  • Category: General Payments
  • Program years: PY2022–2024
  • Record count: 49
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $632.90 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $632.9021

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2022 $323.7210
2023 $479.9718
2024 $632.9021

Records — PY2024 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078723579 Janssen Biotech, Inc. $33.79 09/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078860185 Janssen Scientific Affairs, LLC $27.34 11/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1091987837 Ipsen Biopharmaceuticals, Inc $33.37 08/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101177980 Celgene Corporation $28.19 01/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101177982 Celgene Corporation $21.93 01/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101177986 Celgene Corporation $22.87 10/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101177988 Celgene Corporation $33.13 11/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105405229 AstraZeneca Pharmaceuticals LP $23.73 05/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1108301870 ABBVIE INC. $33.78 10/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114407340 Regeneron Pharmaceuticals, Inc. $50.84 09/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114407342 Regeneron Pharmaceuticals, Inc. $65.37 09/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1121187584 ADC Therapeutics America, Inc. $22.12 05/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1121187594 ADC Therapeutics America, Inc. $18.74 07/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1134021767 Azurity Pharmaceuticals, Inc. $23.07 05/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135646425 Lilly USA, LLC $22.25 04/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135711190 Lilly USA, LLC $33.08 10/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135713610 Lilly USA, LLC $27.60 03/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1138634813 BTG International, Inc. $23.71 06/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141188949 Incyte Corporation $29.79 12/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141306097 Incyte Corporation $28.36 05/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145539874 Karyopharm Therapeutics Inc. $29.84 09/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.